Starsource Multitrade Limited has announced that its register of members and share transfer books will remain closed from Tuesday, September 22, 2026, to Saturday, September 27, 2026. This closure is for the purpose of its 84th Annual General Meeting, scheduled for Monday, September 28, 2026.

The company, formerly known as Chemo Pharma Laboratories Limited, confirmed that the record date for e-voting is set for Monday, September 21, 2026. Shareholders holding equity shares of face value ₹10 each on this record date will be eligible to vote at the AGM.

Meeting Details

The 84th AGM will be conducted through Video Conferencing or Other Audio-Visual Means (VC/OAVM) in compliance with SEBI and MCA regulations. The meeting is scheduled for 4:00 pm on September 28, 2026.

The Board of Directors approved these details during a meeting held on Tuesday, September 1, 2026, at the company’s registered office in Kalyan. The board also appointed a scrutinizer for the meeting and fixed the book closure dates.

Compliance and Filings

Starsource Multitrade filed the intimation regarding the book closure with the Bombay Stock Exchange on September 1, 2026. This filing was made pursuant to Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and Section 91 of the Companies Act, 2013.

Previously, the company published newspaper advertisements in Business Standard and Mumbai Lakshdeep on August 31, 2026, to inform equity shareholders about the virtual meeting format. The initial intimation for the AGM was filed with BSE on August 27, 2026.

Starsource Multitrade Limited (formerly Chemo Pharma Laboratories Limited) reported its unaudited financial results for the quarter ended June 30, 2026. The company posted a consolidated net profit of ₹6.1 crore against income from operations of ₹86.4 crore. On a standalone basis, net profit was ₹1.3 crore on revenue of ₹18.6 crore.

The Board of Directors approved the results in a meeting held on August 14, 2026. The financial statements were prepared in accordance with the Companies (Indian Accounting Standards) Rules, 2015 (Ind AS) prescribed under Section 133 of the Companies Act, 2013.

Financial Highlights

What the Numbers Show

The divergence between standalone and consolidated figures indicates significant contribution from subsidiaries or associates. While standalone operations generated ₹18.6 crore in revenue, the consolidated top line was ₹86.4 crore, suggesting that the majority of the company's operational activity is captured through its group entities. The consolidated net profit margin stood at approximately 7%, compared to a 7% margin on a standalone basis, indicating consistent profitability across both structures.

Regulatory Disclosures

Pursuant to Regulation 47 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, the company published the unaudited financial results in Business Standard and Mumbai Lakshdeep on August 15, 2026. The results were reviewed by the Audit Committee before board approval.

The full format of the financial results is available on the company's website and the stock exchange portals. Figures have been regrouped and rearranged wherever necessary to align with current period classification.